BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th Edition: part II and III. Esophagus. 2017;14:37-65. [PMID: 28111536 DOI: 10.1007/s10388-016-0556-2] [Cited by in Crossref: 152] [Cited by in F6Publishing: 148] [Article Influence: 25.3] [Reference Citation Analysis]
Number Citing Articles
1 Shiozaki A, Kudou M, Fujiwara H, Konishi H, Shimizu H, Arita T, Kosuga T, Yamamoto Y, Morimura R, Ikoma H, Kuriu Y, Kubota T, Okamoto K, Otsuji E. Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma: Phase I/II study (TNAC). Medicine (Baltimore) 2020;99:e23633. [PMID: 33327342 DOI: 10.1097/MD.0000000000023633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tang H, Tan L, Wang H, Shen Y, Yin J, Fang Y, Wang Q. Is Routine Subcarinal Lymph Node Dissection Necessary in Superficial Esophageal Squamous Cell Carcinoma? A Propensity Score Matching Analysis. J Cancer 2019;10:2350-6. [PMID: 31258738 DOI: 10.7150/jca.30474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Sano J, Matsuda S, Kawakubo H, Takemura R, Okui J, Irino T, Fukuda K, Nakamura R, Kitagawa Y. Exposure to a Postoperative Hypercoagulable State Predicts Poor Prognosis After Transthoracic Esophagectomy in Patients with Esophageal Cancer. Ann Surg Oncol. [DOI: 10.1245/s10434-022-11591-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nishiwaki N, Noma K, Kunitomo T, Hashimoto M, Maeda N, Tanabe S, Sakurama K, Shirakawa Y, Fujiwara T. Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis. Esophagus. [DOI: 10.1007/s10388-022-00934-5] [Reference Citation Analysis]
5 Tanaka K, Yamasaki M, Sugimura K, Shiraishi O, Motoori M, Hamakawa T, Takeno A, Yamashita K, Makino T, Kimura Y, Miyata H, Hirao M, Eguchi H, Yasuda T, Yano M, Doki Y. Thoracic Duct Resection Has a Favorable Impact on Prognosis by Preventing Hematogenous Spread of Esophageal Cancer Cells: A Multi-institutional Analysis of 2269 Patients. Ann Surg Oncol 2021;28:4402-10. [PMID: 33861403 DOI: 10.1245/s10434-021-09962-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shimada A, Tanaka M, Ishii S, Okamoto N, Yamamoto Y, Osaki M, Nishijima W, Omura K, Wakabayashi G. Utility of Concurrent Surgical Treatment Strategy with Thoracoscopic Esophagectomy for Patients with Synchronous Esophageal and Head and Neck Cancer. J Laparoendosc Adv Surg Tech A 2022;32:550-5. [PMID: 35443808 DOI: 10.1089/lap.2021.0441] [Reference Citation Analysis]
7 Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Li SH. The Clinical Outcomes of Locally Advanced Cervical Esophageal Squamous Cell Carcinoma Patients Receiving Curative Concurrent Chemoradiotherapy: A Population-Based Propensity Score-Matched Analysis. Cancers (Basel) 2019;11:E451. [PMID: 30934987 DOI: 10.3390/cancers11040451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Matsuda S, Kawakubo H, Okamura A, Takahashi K, Toihata T, Takemura R, Mayanagi S, Takeuchi H, Watanabe M, Kitagawa Y. Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 34142294 DOI: 10.1245/s10434-021-10221-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hoshino S, Takeuchi M, Kawakubo H, Kobayashi R, Matsuda S, Irino T, Fukuda K, Nakamura R, Kitagawa Y. Neutrophil-to-lymphocyte ratio change predicts histological response to and oncological outcome of neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Esophagus. [DOI: 10.1007/s10388-021-00901-6] [Reference Citation Analysis]
10 Kang CH. Totally Robotic Esophagectomy. J Chest Surg 2021;54:302-9. [PMID: 34353971 DOI: 10.5090/jcs.21.069] [Reference Citation Analysis]
11 Chen M, Liu P, Chen Y, Chen Z, Shen M, Liu X, Li X, Lin Y, Yang R, Ni W, Zhou X, Zhang L, Tian Y, Chen J. Primary tumor regression patterns in esophageal squamous cell cancer treated with definitive chemoradiotherapy and implications for surveillance schemes. Cancer Manag Res. 2019;11:3361-3369. [PMID: 31114372 DOI: 10.2147/cmar.s198524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Braun S, Ell C, Lorenz D. Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma. World J Surg. 2020;44:1192-1199. [PMID: 31853591 DOI: 10.1007/s00268-019-05291-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zhuang X, Xu M, Chen Z, Wang J, Qian K, Wang S, Deng G, Bai Y. Predictors for Submucosal Fibrosis in Patients With Superficial Squamous Esophageal Neoplasia Undergoing Endoscopic Submucosal Dissection. Clin Transl Gastroenterol 2020;11:e00188. [PMID: 32955196 DOI: 10.14309/ctg.0000000000000188] [Reference Citation Analysis]
14 Marginean EC, Dhanpat J. Pathologic assessment of endoscopic resection specimens with superficial carcinoma of the esophagus: current practice and practical issues. Ann N Y Acad Sci 2020;1482:130-45. [PMID: 32875588 DOI: 10.1111/nyas.14455] [Reference Citation Analysis]
15 Matsubara T, Hirahara N, Zotani H, Tabara N, Tabara H, Tajima Y. Three-dimensional computed tomography image-oriented successful thoracoscopic subtotal esophagectomy for an esophageal cancer patient with an anomalous right superior pulmonary vein: A case report. Int J Surg Case Rep 2020;76:178-82. [PMID: 33038843 DOI: 10.1016/j.ijscr.2020.09.196] [Reference Citation Analysis]
16 Sugimura K, Miyata H, Motoori M, Omori T, Fujiwara Y, Yano M. The Significance of SCC and CEA mRNA in the Pleural Cavity After Lymphadenectomy in Esophageal Cancer Patients who Underwent Preoperative Treatment. World J Surg 2018;42:749-57. [DOI: 10.1007/s00268-017-4203-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Ohkura Y, Shindoh J, Ueno M, Iizuka T, Udagawa H. Comparison of Outcome of Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer with Clinical Complete Response to Neoadjuvant Therapy. Ann Surg Oncol 2018;25:2428-33. [DOI: 10.1245/s10434-018-6437-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
18 Schizas D, Kapsampelis P, Mylonas KS MD. Adenosquamous Carcinoma of the Esophagus: A Literature Review. J Transl Int Med. 2018;6:70-73. [PMID: 29984200 DOI: 10.2478/jtim-2018-0014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
19 Matsubara H. Advances in the surgical treatment of esophageal cancer since 1965. Ann Gastroenterol Surg 2020;4:243-9. [PMID: 32490339 DOI: 10.1002/ags3.12332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Sugawara K, Yagi K, Okumura Y, Nishida M, Aikou S, Yamashita H, Seto Y. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma. Int J Clin Oncol. 2020;25:552-560. [PMID: 31828451 DOI: 10.1007/s10147-019-01590-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Booka E, Haneda R, Ishii K, Kawakami T, Tsushima T, Yasui H, Onoe T, Ogawa H, Tsubosa Y. Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020;27:3163-3170. [PMID: 32314159 DOI: 10.1245/s10434-020-08440-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
22 Furukawa K, Niihara M, Kawata T, Mayanagi S, Tsubosa Y. Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report. Surg Case Rep 2020;6:26. [PMID: 31960152 DOI: 10.1186/s40792-020-0785-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Lam AK. Updates on World Health Organization classification and staging of esophageal tumors: implications for future clinical practice. Hum Pathol 2021;108:100-12. [PMID: 33157124 DOI: 10.1016/j.humpath.2020.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hashimoto M, Kitagami H, Niwa H, Kikkawa T, Ohuchi T, Takenouchi T, Hosokawa M. Prognosis and prognostic factors of esophageal spindle cell carcinoma treated by esophagectomy: a retrospective single-institution analysis. Esophagus. 2019;16:292-299. [PMID: 30937574 DOI: 10.1007/s10388-019-00667-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
25 Fujiwara H, Kanamori J, Nakajima Y, Kawano T, Miura A, Fujita T, Akita K, Daiko H. An anatomical hypothesis: a "concentric-structured model" for the theoretical understanding of the surgical anatomy in the upper mediastinum required for esophagectomy with radical mediastinal lymph node dissection. Dis Esophagus 2019;32:doy119. [PMID: 30561581 DOI: 10.1093/dote/doy119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
26 Yamashita H, Kadota T, Minamide T, Sunakawa H, Sato D, Takashima K, Nakajo K, Murano T, Shinmura K, Yoda Y, Ikematsu H, Yano T. Efficacy and safety of second photodynamic therapy for local failure after salvage photodynamic therapy for esophageal cancer. Dig Endosc 2021. [PMID: 34185928 DOI: 10.1111/den.14072] [Reference Citation Analysis]
27 Kawakita Y, Motoyama S, Sato Y, Wakita A, Nagaki Y, Imai K, Minamiya Y. Decreases in the Psoas Muscle Index Correlate More Strongly with Survival than Other Prognostic Markers in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Plus Esophagectomy. World J Surg 2020;44:1559-68. [PMID: 31907570 DOI: 10.1007/s00268-019-05344-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Yamauchi T, Fujishima F, Hashimoto M, Tsunokake J, Akaishi R, Gokon Y, Ueki S, Ozawa Y, Fukutomi T, Okamoto H, Sato C, Taniyama Y, Nakamura T, Nakaya N, Kamei T, Sasano H. Necroptosis in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Its Correlation with Tumor-Infiltrating Lymphocytes. Cancers (Basel) 2021;13:4473. [PMID: 34503283 DOI: 10.3390/cancers13174473] [Reference Citation Analysis]
29 Fujishima H, Fumoto S, Shibata T, Nishiki K, Tsukamoto Y, Etoh T, Moriyama M, Shiraishi N, Inomata M. A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer. PLoS One 2017;12:e0188098. [PMID: 29136005 DOI: 10.1371/journal.pone.0188098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
30 Komatsu S, Otsuji E. Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan. Ann Gastroenterol Surg 2019;3:581-91. [PMID: 31788646 DOI: 10.1002/ags3.12284] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
31 Ishida T, Makino T, Yamasaki M, Yamashita K, Tanaka K, Saito T, Yamamoto K, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Eguchi H, Doki Y. Quantity and Quality of Skeletal Muscle as an Important Predictor of Clinical Outcomes in Patients with Esophageal Cancer Undergoing Esophagectomy after Neoadjuvant Chemotherapy. Ann Surg Oncol 2021. [PMID: 33876359 DOI: 10.1245/s10434-021-10025-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Wang X, Wang H, Wang H, Huang J, Wang X, Jiang Z, Tan L, Jiang D, Hou Y. Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery. BMC Cancer 2021;21:111. [PMID: 33535987 DOI: 10.1186/s12885-020-07779-0] [Reference Citation Analysis]
33 Takeuchi A, Hatta W, Koike T, Saito M, Jin X, Asanuma K, Uno K, Asano N, Imatani A, Fujishima F, Masamune A. A Primary Barrett's Adenocarcinoma with a Squamous Cell Carcinoma Component. Intern Med 2019;58:2467-72. [PMID: 31118396 DOI: 10.2169/internalmedicine.2722-19] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Nakatani Y, Kato K, Shoji H, Iwasa S, Honma Y, Takashima A, Ushijima T, Ito Y, Itami J, Boku N. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer. Int J Clin Oncol 2020;25:1098-104. [PMID: 32189155 DOI: 10.1007/s10147-020-01652-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Yoshimoto T, Kobayashi S, Kanetaka K, Kobayashi K, Nagata Y, Morita M, Isagawa Y, Kinoshita N, Takatsuki M, Eguchi S. Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature. Surg Case Rep 2018;4:18. [PMID: 29455418 DOI: 10.1186/s40792-018-0425-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
36 Nitta T, Kawai M, Kataoka J, Ohta M, Tashiro K, Ishibashi T. Combined Intraoperative Identification and Monitoring of Recurrent Laryngeal Nerve Paresis during Minimally Invasive Esophagectomy: Surgical Technique Using Nerve Integrity Monitoring for Esophageal Carcinoma. Case Rep Gastroenterol 2020;14:644-51. [PMID: 33442344 DOI: 10.1159/000510209] [Reference Citation Analysis]
37 Oguma J, Ozawa S, Sakakibara T, Kajiwara H, Nakamura N, Makuuchi H. Prognostic impact of LY6K and CDCA1 expression for patients with esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2021;5:194-203. [PMID: 33860139 DOI: 10.1002/ags3.12415] [Reference Citation Analysis]
38 Ego M, Abe S, Nakatani Y, Nonaka S, Suzuki H, Yoshinaga S, Oda I, Kato K, Honma Y, Itami J, Daiko H, Saito Y, Boku N. Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy. Surg Endosc 2021;35:1766-76. [PMID: 32356109 DOI: 10.1007/s00464-020-07571-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Mo R, Chen C, Pan L, Yu A, Wang D, Wang T. Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8th edition of the TNM staging system for esophageal cancer? J Thorac Dis 2018;10:5192-8. [PMID: 30416766 DOI: 10.21037/jtd.2018.08.98] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
40 Fukumoto Y, Matsunaga T, Shishido Y, Amisaki M, Kono Y, Murakami Y, Kuroda H, Osaki T, Sakamoto T, Honjo S, Ashida K, Saito H, Fujiwara Y. Successful repair using thymus pedicle flap for tracheoesophageal fistula: a case report. Surg Case Rep 2018;4:49. [PMID: 29796790 DOI: 10.1186/s40792-018-0458-8] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Zhang G, Li Y, Wang Q, Zheng H, Yuan L, Gao Z, Li J, Li X, Zhao S. Development of a prediction model for the risk of recurrent laryngeal nerve lymph node metastasis in thoracolaparoscopic esophagectomy with cervical anastomosis. Ann Transl Med 2021;9:990. [PMID: 34277790 DOI: 10.21037/atm-21-2374] [Reference Citation Analysis]
42 Nakao R, Konishi E, Fujiwara H, Otsuji E, Yokota I, Urata Y, Yanagisawa A. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy. Int J Surg Pathol 2019;27:713-21. [PMID: 31203677 DOI: 10.1177/1066896919855760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Chen H, Yang R, Yu X, Jiang X, Jiang L, Zhang G, Zhou X. Establishment of a Preoperative Laboratory Panel to identify Lymph Node Metastasis in Superficial Esophageal Cancer. J Cancer 2022;13:2238-45. [PMID: 35517400 DOI: 10.7150/jca.71114] [Reference Citation Analysis]
44 Yago A, Ohkura Y, Ueno M, Fujisawa K, Ogawa Y, Shimoyama H, Haruta S, Udagawa H. Importance of long-term surveillance after curative esophagectomy for esophageal squamous cell carcinoma. Dis Esophagus 2022:doab098. [PMID: 35032162 DOI: 10.1093/dote/doab098] [Reference Citation Analysis]
45 Kubo K, Wadasaki K, Shinozaki K. Treatment outcomes according to the macroscopic tumor type in locally advanced esophageal squamous cell carcinoma treated by chemoradiotherapy. Jpn J Radiol 2019;37:341-9. [DOI: 10.1007/s11604-019-00814-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Shishido Y, Saito H, Shimizu S, Kono Y, Murakami Y, Miyatani K, Matsunaga T, Yamamoto M, Fukumoto Y, Honjo S, Fujiwara Y. Prognostic significance of platelet × C-reactive protein multiplier in patients with esophageal squamous cell carcinoma. Surg Today 2020;50:185-92. [DOI: 10.1007/s00595-019-01865-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Grillo F, Mastracci L, Saragoni L, Vanoli A, Limarzi F, Gullo I, Ferro J, Paudice M, Parente P, Fassan M. Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction. Pathologica 2020;112:138-52. [PMID: 33179618 DOI: 10.32074/1591-951X-164] [Reference Citation Analysis]
48 Miyamoto Y, Nonaka S, Oda I, Abe S, Suzuki H, Yoshinaga S, Mano H, Saito Y. Safety and usefulness of endoscopic submucosal dissection for early esophageal cancers in elderly patients aged 80 years or older. Esophagus 2021;18:81-9. [PMID: 32472275 DOI: 10.1007/s10388-020-00750-9] [Reference Citation Analysis]
49 Takahashi M, Yoshimura S, Takyu S, Aikou S, Okumura Y, Yagi K, Fukayama M, Momose T, Seto Y, Yamaya T. A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients. Ann Nucl Med 2021. [PMID: 34843102 DOI: 10.1007/s12149-021-01701-9] [Reference Citation Analysis]
50 Nakajo K, Yoda Y, Yamashita H, Takashima K, Murano T, Kadota T, Shinmura K, Ikematsu H, Akimoto T, Yano T. Salvage endoscopic resection for cT1N0M0 local recurrence after chemoradiotherapy for esophageal squamous cell carcinoma: endoscopic submucosal dissection versus endoscopic mucosal resection. Jpn J Clin Oncol 2022:hyac090. [PMID: 35675653 DOI: 10.1093/jjco/hyac090] [Reference Citation Analysis]
51 Ikawa T, Ishihara R, Konishi K, Morimoto M, Hirata T, Kanayama N, Yamamoto S, Matsuura N, Wada K, Hayashi K, Ogawa K, Teshima T. Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma. Cancer Med 2019;8:4547-54. [PMID: 31222974 DOI: 10.1002/cam4.2365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Hamai Y, Hihara J, Emi M, Ibuki Y, Murakami Y, Nishibuchi I, Nagata Y, Aoki Y, Furukawa T, Okada M. Clinical Significance of 18F-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2019;26:1869-78. [PMID: 30675704 DOI: 10.1245/s10434-019-07158-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
53 Kono M, Kanesaka T, Ishihara R, Kitamura M, Shoji A, Inoue T, Matsueda K, Miyake M, Waki K, Shimamoto Y, Fukuda H, Iwagami H, Matsuura N, Nakahira H, Shichijo S, Maekawa A, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Michida T, Nakatsuka SI, Fujiwara Y. Delineating the extent of esophageal squamous cell carcinoma. Esophagus 2021;18:790-6. [PMID: 34052934 DOI: 10.1007/s10388-021-00854-w] [Reference Citation Analysis]
54 Huang Z, Li S, Yang X, Lu F, Huang M, Zhang S, Xiong Y, Zhang P, Si J, Ma Y, Yang Y. Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study. Cancer Manag Res 2019;11:1299-308. [PMID: 30799956 DOI: 10.2147/CMAR.S195355] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Sakakibara T, Ozawa S, Oguma J, Nakui M, Yamamoto S, Makuuchi H, Kajiwara H, Nakamura N. Prognostic significance of IMP-3 expression pattern in esophageal squamous cell carcinoma. J Thorac Dis 2019;11:3776-84. [PMID: 31656650 DOI: 10.21037/jtd.2019.09.25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Shirakawa Y, Noma K, Maeda N, Ninomiya T, Tanabe S, Kikuchi S, Kuroda S, Nishizaki M, Kagawa S, Kawahara Y, Okada H, Fujiwara T. Clinical characteristics and management of gastric tube cancer after esophagectomy. Esophagus. 2018;15:180-189. [PMID: 29951985 DOI: 10.1007/s10388-018-0611-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
57 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Fisseler-Eckhoff A, Braun S, Ell C, Lorenz D. The overall metastatic rate in early esophageal adenocarcinoma: long-time follow-up of surgically treated patients. Dis Esophagus 2019;32:doy127. [PMID: 30596900 DOI: 10.1093/dote/doy127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Liu GY, Zhang JX, Rong L, Nian WD, Nian BX, Tian Y. Esophageal superficial adenosquamous carcinoma resected by endoscopic submucosal dissection: A rare case report. World J Clin Cases 2021; 9(6): 1336-1342 [PMID: 33644200 DOI: 10.12998/wjcc.v9.i6.1336] [Reference Citation Analysis]
59 Tokunaga M, Matsumura T, Ishikawa K, Kaneko T, Oura H, Ishikawa T, Nagashima A, Shiratori W, Okimoto K, Akizue N, Maruoka D, Ohta Y, Saito K, Nakagawa T, Chiba T, Arai M, Kato J, Kato N. The Efficacy of Linked Color Imaging in the Endoscopic Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Res Pract 2020;2020:9604345. [PMID: 33061962 DOI: 10.1155/2020/9604345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Hoshino I, Gunji H, Ishige F, Iwatate Y, Takiguchi N, Ikeda A, Soda H, Tonooka T, Sato N, Kawahara K, Nabeya Y. Surgical treatment strategy for esophagogastric junction cancers based on the tumor diameter. BMC Surg 2019;19:152. [PMID: 31651313 DOI: 10.1186/s12893-019-0614-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
61 Akaishi R, Fujishima F, Ishida H, Tsunokake J, Yamauchi T, Gokon Y, Ueki S, Fukutomi T, Okamoto H, Takaya K, Sato C, Taniyama Y, Nakamura T, Nakaya N, Kamei T, Sasano H. Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma. Esophagus 2022. [PMID: 34999996 DOI: 10.1007/s10388-021-00904-3] [Reference Citation Analysis]
62 Hagi T, Makino T, Yamasaki M, Tanaka K, Nishida N, Sakai D, Motoori M, Kimura Y, Satoh T, Mori M, Doki Y. Dysphagia Score as a Predictor of Adverse Events Due to Triplet Chemotherapy and Oncological Outcomes in 434 Consecutive Patients with Esophageal Cancer. Ann Surg Oncol 2019;26:4754-64. [DOI: 10.1245/s10434-019-07744-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
63 Kuwabara H, Chiba H, Tachikawa J, Okada N, Ashikari K, Arimoto J, Nakaoka M, Sakai E, Goto T, Ohata K. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus. Dig Endosc 2020;32:621-7. [PMID: 31965622 DOI: 10.1111/den.13631] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Ma Y, Yao X, Li Z, Chen J, Li W, Wang H, Zhang L, Zhu J. The role of vascular invasion and lymphatic invasion in predicting recurrent thoracic oesophageal squamous cell carcinoma. World J Surg Oncol 2022;20:12. [PMID: 35012555 DOI: 10.1186/s12957-021-02458-1] [Reference Citation Analysis]
65 Shirakawa Y, Noma K, Kunitomo T, Hashimoto M, Maeda N, Tanabe S, Sakurama K, Fujiwara T. Initial introduction of robot-assisted, minimally invasive esophagectomy using the microanatomy-based concept in the upper mediastinum. Surg Endosc 2020. [PMID: 33170337 DOI: 10.1007/s00464-020-08154-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Chen M, Shen M, Lin Y, Liu P, Liu X, Li X, Li A, Yang R, Ni W, Zhou X, Zhang L, Xu B, Lin J, Chen J, Tian Y. Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Radiat Oncol 2018;13:150. [PMID: 30111361 DOI: 10.1186/s13014-018-1086-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
67 Furue Y, Katada C, Tanabe S, Ishido K, Kondo Y, Kubota Y, Kawanishi N, Yamane S, Watanabe A, Moriya H, Yamashita K, Wada T, Yano T, Azuma M, Koizumi W. Effectiveness and safety of endoscopic aspiration mucosectomy and endoscopic submucosal dissection in patients with superficial esophageal squamous-cell carcinoma. Surg Endosc 2019;33:1433-40. [PMID: 30187201 DOI: 10.1007/s00464-018-6418-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
68 Kuan JY, Baskind S, Kim Y, McGrath S, Chaparala R, Assadsangabi A, Prasad N, Regi G, Ang Y. Endoscopic resection of early squamous neoplasia of the oesophagus: long-term follow-up in a UK population from a tertiary hospital. Eur J Gastroenterol Hepatol 2020;32:789-96. [PMID: 32302087 DOI: 10.1097/MEG.0000000000001692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Hikage M, Taniyama Y, Sakurai T, Sato C, Takaya K, Okamoto H, Konno T, Ujiie N, Naitoh T, Unno M, Kamei T. The Influence of the Perioperative Nutritional Status on the Survival Outcomes for Esophageal Cancer Patients with Neoadjuvant Chemotherapy. Ann Surg Oncol 2019;26:4744-53. [PMID: 31440925 DOI: 10.1245/s10434-019-07742-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
70 Ikawa T, Ishihara R, Matsueda K, Konishi K, Yamamoto S, Morimoto M, Kanayama N, Teshima T. Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study. BMC Cancer 2022;22:301. [PMID: 35313853 DOI: 10.1186/s12885-022-09418-2] [Reference Citation Analysis]
71 Mori Y, Kikuchi O, Horimatsu T, Hara H, Hironaka S, Kojima T, Kato K, Tsushima T, Ishihara R, Mukai K, Uozumi R, Tada H, Kasai H, Kawaguchi A, Muto M. Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study. Esophagus 2022. [PMID: 35050435 DOI: 10.1007/s10388-021-00905-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Yoshimura S, Takahashi M, Aikou S, Okumura Y, Jinbo K, Onoyama H, Urabe M, Kawasaki K, Yagi K, Nishida M, Mori K, Yamashita H, Nomura S, Koyama K, Momose T, Abe H, Ushiku T, Fukayama M, Seto Y. One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer. Clin Nucl Med 2020;45:741-6. [PMID: 32796247 DOI: 10.1097/RLU.0000000000003224] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Mora A, Kawada K, Nakajima Y, Okada T, Tokairin Y, Kawano T. Mid- and long-term outcomes of endoscopic resection for submucosal esophageal cancer types pT1b-SM1 and pT1b-SM2. Endosc Int Open 2019;7:E733-42. [PMID: 31157290 DOI: 10.1055/a-0838-5180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Hasatani K, Tamamura H, Yamamoto K, Aoyagi H, Miyanaga T, Kaizaki Y, Sawada T. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer. Digestion 2020;101:366-74. [PMID: 31067539 DOI: 10.1159/000500039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 Kadota T, Abe S, Yoda Y, Yoshinaga S, Oda I, Kojima T, Kato K, Daiko H, Yano T. Clinical outcomes according to the modified endoscopic criteria for neoadjuvant chemotherapy in resectable esophageal squamous cell carcinoma. Dig Endosc 2020;32:337-45. [PMID: 31295769 DOI: 10.1111/den.13483] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Aida J, Ishizaki T, Arai T, Takubo K. Prognostication of superficial Barrett’s carcinoma: a Japanese multicenter study. Human Pathology 2018;76:156-66. [DOI: 10.1016/j.humpath.2018.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Shimamoto Y, Ishihara R, Kato Y, Shoji A, Inoue T, Matsueda K, Miyake M, Waki K, Kono M, Fukuda H, Matsuura N, Nagaike K, Aoi K, Yamamoto K, Nakahara M, Nishihara A, Tada T. Real-time assessment of video images for esophageal squamous cell carcinoma invasion depth using artificial intelligence. J Gastroenterol. 2020;55:1037-1045. [PMID: 32778959 DOI: 10.1007/s00535-020-01716-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
78 Kataoka A, Yamada K, Hagiwara T, Terayama M, Sugimoto T, Nohara K, Igari T, Yokoi C, Kawamura YI. Expression Status of Serine Protease 27: A Prognostic Marker for Esophageal Squamous Cell Carcinoma Treated with Preoperative Chemotherapy/Chemoradiotherapy. Ann Surg Oncol 2021;28:5373-81. [PMID: 33452606 DOI: 10.1245/s10434-020-09550-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Roy R, Kandimalla R, Sonohara F, Koike M, Kodera Y, Takahashi N, Yamada Y, Goel A. A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma. Int J Cancer 2019;144:1160-9. [PMID: 30006931 DOI: 10.1002/ijc.31755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
80 Xue LY, Qin XM, Liu Y, Liang J, Lin H, Xue XM, Zou SM, Zhang MY, Zhang BH, Hui ZG, Zhao ZT, Ren LQ, Zhang YM, Liu XY, Yuan YL, Ying JM, Gao SG, Song YM, Wang GQ, Dawsey SM, Lu N. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma. World J Gastroenterol 2018; 24(45): 5154-5166 [PMID: 30568392 DOI: 10.3748/wjg.v24.i45.5154] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
81 Ishida T, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Mori M, Doki Y. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy. Surgery 2019;166:1041-7. [PMID: 31607486 DOI: 10.1016/j.surg.2019.07.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
82 Nakanoko T, Morita M, Nakashima Y, Ota M, Ikebe M, Yamamoto M, Booka E, Takeuchi H, Kitagawa Y, Matsubara H, Doki Y, Toh Y. Nationwide survey of the follow-up practices for patients with esophageal carcinoma after radical treatment: historical changes and future perspectives in Japan. Esophagus 2021. [PMID: 34383154 DOI: 10.1007/s10388-021-00869-3] [Reference Citation Analysis]
83 Berlth F, Hoelscher AH. History of Esophagogastric Junction Cancer Treatment and Current Surgical Management in Western Countries. J Gastric Cancer 2019;19:139-47. [PMID: 31245158 DOI: 10.5230/jgc.2019.19.e18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
84 Harada H, Hosoda K, Moriya H, Mieno H, Ema A, Washio M, Kikuchi M, Kosaka Y, Watanabe M, Yamashita K. Carcinosarcoma of the esophagus: A report of 6 cases associated with zinc finger E-box-binding homeobox 1 expression. Oncol Lett. 2019;17:578-586. [PMID: 30655804 DOI: 10.3892/ol.2018.9585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
85 Katsurahara K, Shiozaki A, Fujiwara H, Konishi H, Kudou M, Shoda K, Arita T, Kosuga T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Kubota T, Nakanishi M, Okamoto K, Otsuji E. Clinical significance of the distance between the cricoid cartilage and upper edge of the tumor using PET-CT in cervical esophageal cancer. Oncol Lett 2020;20:40. [PMID: 32788935 DOI: 10.3892/ol.2020.11901] [Reference Citation Analysis]
86 Kuwabara H, Abe S, Nonaka S, Suzuki H, Yoshinaga S, Oda I, Saito Y. Clinical feasibility of endoscopic submucosal dissection with minimum lateral margin of superficial esophageal squamous cell carcinoma. Endosc Int Open 2019;7:E396-402. [PMID: 30931369 DOI: 10.1055/a-0838-5064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Sun X, Niwa T, Ozawa S, Endo J, Hashimoto J. Detecting lymph node metastasis of esophageal cancer on dual-energy computed tomography. Acta Radiol 2022;63:3-10. [PMID: 33325727 DOI: 10.1177/0284185120980144] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Zhang W, Chen H, Zhang G, Jin G. A nomogram for predicting lymph node metastasis in superficial esophageal squamous cell carcinoma. J Biomed Res 2021;35:361-70. [PMID: 34628403 DOI: 10.7555/JBR.35.20210034] [Reference Citation Analysis]
89 Wei MT, Friedland S. Early Esophageal Cancer: What the Gastroenterologist Needs to Know. Gastroenterol Clin North Am 2021;50:791-808. [PMID: 34717871 DOI: 10.1016/j.gtc.2021.07.004] [Reference Citation Analysis]
90 Hatta W, Koike T, Ogata Y, Kondo Y, Ara N, Uno K, Asano N, Imatani A, Masamune A. Comparison of Magnifying Endoscopy with Blue Light Imaging and Narrow Band Imaging for Determining the Invasion Depth of Superficial Esophageal Squamous Cell Carcinoma by the Japanese Esophageal Society's Intrapapillary Capillary Loop Classification. Diagnostics (Basel) 2021;11:1941. [PMID: 34829288 DOI: 10.3390/diagnostics11111941] [Reference Citation Analysis]
91 Liu J, Yang Y, Liu Z, Fu X, Cai X, Li H, Zhu L, Shen Y, Zhang H, Sun Y, Chen H, Yu B, Zhang R, Shao J, Zhang M, Li Z. Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma. J Immunother Cancer 2022;10:e004291. [PMID: 35338088 DOI: 10.1136/jitc-2021-004291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
92 Namikawa K, Yoshio T, Yoshimizu S, Ishiyama A, Tsuchida T, Tokai Y, Horiuchi Y, Hirasawa T, Fujisaki J. Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma. Sci Rep 2021;11:6554. [PMID: 33753766 DOI: 10.1038/s41598-021-85572-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Liu Y, Zou ZQ, Xiao J, Zhang M, Yuan L, Zhao XG. A nomogram prediction model for recurrent laryngeal nerve lymph node metastasis in thoracic oesophageal squamous cell carcinoma. J Thorac Dis 2019;11:2868-77. [PMID: 31463116 DOI: 10.21037/jtd.2019.06.46] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
94 Ueki S, Fujishima F, Kumagai T, Ishida H, Okamoto H, Takaya K, Sato C, Taniyma Y, Kamei T, Sasano H. GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy. BMC Cancer 2020;20:161. [PMID: 32106831 DOI: 10.1186/s12885-020-6652-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
95 Wang Y, Juma AN, Chen Y, Peng X, Zhou Y, Wei Z. Four synchronous primary cancers of the aerodigestive tract and thyroid. Asian Cardiovasc Thorac Ann 2017;25:645-8. [PMID: 29152991 DOI: 10.1177/0218492317741787] [Reference Citation Analysis]
96 Zhang J, Liu Y, Che F, Luo Y, Huang W, Heng X, Li B. Pattern of lymph node metastasis in thoracic esophageal squamous cell carcinoma with poor differentiation. Mol Clin Oncol 2018;8:760-6. [PMID: 29844907 DOI: 10.3892/mco.2018.1606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
97 Udagawa H. Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer. Ann Gastroenterol Surg 2020;4:324-30. [PMID: 32724875 DOI: 10.1002/ags3.12338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
98 Li Y, Liu J, Li HX, Cai XW, Li ZG, Ye XD, Teng HH, Fu XL, Yu W. Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy. Front Oncol 2020;10:615167. [PMID: 33680935 DOI: 10.3389/fonc.2020.615167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Gamboa AC, Meyer BI, Switchenko JM, Rupji M, Lee RM, Turgeon MK, Russell MC, Cardona K, Kooby DA, Maithel SK, Shah MM. Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma? J Surg Oncol 2020;122:412-21. [PMID: 32462769 DOI: 10.1002/jso.25990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Zhuang X, Chen Z, Wang J, Chen J, Wu X, Wang Y, Chen C, Deng G, Qian K, Bai Y. Clinicopathological features and outcomes of esophageal lesions containing a basal layer type squamous cell carcinoma component. Cancer Manag Res 2019;11:8507-16. [PMID: 31572005 DOI: 10.2147/CMAR.S212380] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
101 Sasaki K, Uchikado Y, Omoto I, Arigami T, Osako Y, Noda M, Okumura H, Maemura K, Higashi R, Yoshiura T, Natsugoe S. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma. Cancer Chemother Pharmacol 2019;83:581-7. [DOI: 10.1007/s00280-018-03764-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
102 Li H, Zhang ZR. Current status and future direction of lymph node dissection in radical surgery for esophageal cancer. J Thorac Dis 2019;11:S1678-82. [PMID: 31516741 DOI: 10.21037/jtd.2019.05.51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
103 Sugawara K, Mori K, Yagi K, Aikou S, Uemura Y, Yamashita H, Seto Y. Association of preoperative inflammation-based prognostic score with survival in patients undergoing salvage esophagectomy. Dis Esophagus 2019;32:doy066. [PMID: 30535140 DOI: 10.1093/dote/doy066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
104 Nagaki Y, Motoyama S, Sato Y, Wakita A, Fujita H, Sasaki Y, Imai K, Minamiya Y. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy. BMC Cancer 2021;21:1192. [PMID: 34753448 DOI: 10.1186/s12885-021-08918-x] [Reference Citation Analysis]
105 Matsuda S, Kawakubo H, Takeuchi H, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2021;5:321-30. [PMID: 34095722 DOI: 10.1002/ags3.12432] [Reference Citation Analysis]
106 Chang X, Deng W, Ni W, Li C, Han W, Gao LR, Wang S, Zhou Z, Chen D, Feng Q, Bi N, Gao S, Lin Y, Chen J, Xiao Z. Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis. Ann Surg Oncol 2021. [PMID: 33969465 DOI: 10.1245/s10434-021-10046-6] [Reference Citation Analysis]
107 Shibamoto J, Fujiwara H, Konishi H, Shiozaki A, Ohashi T, Kubota T, Shimizu H, Arita T, Yamamoto Y, Morimura R, Kuriu Y, Ikoma H, Okamoto K, Otsuji E. Evaluation of subcarinal lymph node dissection and metastasis in transmediastinal radical esophagectomy. Esophagus 2021;18:461-7. [PMID: 33599862 DOI: 10.1007/s10388-021-00824-2] [Reference Citation Analysis]
108 Shishido Y, Matsunaga T, Sawata S, Makinoya M, Miyauchi W, Miyatani K, Uejima C, Morimoto M, Murakami Y, Hanaki T, Kihara K, Yamamoto M, Tokuyasu N, Takano S, Sakamoto T, Saito H, Hasegawa T, Fujiwara Y. Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Yonago Acta Med 2021;64:249-59. [PMID: 34434065 DOI: 10.33160/yam.2021.08.003] [Reference Citation Analysis]
109 Takeuchi M, Kawakubo H, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y. Influence of Neoadjuvant Therapy on Poor Long-Term Outcomes of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study. Ann Surg Oncol 2019;26:2081-9. [PMID: 30937664 DOI: 10.1245/s10434-019-07312-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
110 Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg 2021;273:751-7. [PMID: 31188215 DOI: 10.1097/SLA.0000000000003383] [Reference Citation Analysis]
111 Takao K, Konishi H, Fujiwara H, Shiozaki A, Shoda K, Kosuga T, Kubota T, Arita T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Okamoto K, Otsuji E. Clinical Significance of Prognostic Nutritional Index in the Treatment of Esophageal Squamous Cell Carcinoma. In Vivo 2020;34:3451-7. [PMID: 33144453 DOI: 10.21873/invivo.12184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Sato D, Motegi A, Kadota T, Kojima T, Bando H, Shinmura K, Hori K, Yoda Y, Oono Y, Zenda S, Ikematsu H, Akimoto T, Yano T. Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence. Esophagus 2020;17:305-11. [PMID: 31965362 DOI: 10.1007/s10388-020-00715-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
113 Fukuda S, Watanabe K, Yoshida T, Takahashi S, Fujimori S, Horikawa Y, Komatsu T, Shirane K, Shimodaira Y, Matsuhashi T, Iijima K. Low risk of esophageal adenocarcinoma among patients with ultrashort-segment Barrett's esophagus in Japan. Dig Endosc 2021. [PMID: 34437742 DOI: 10.1111/den.14118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Tanaka T, Ueno M, Iizuka T, Hoteya S, Haruta S, Udagawa H. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma. Dis Esophagus 2019;32:doz023. [PMID: 30980070 DOI: 10.1093/dote/doz023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Matsuda S, Kawakubo H, Tsuji T, Aoyama J, Hirata Y, Takemura R, Mayanagi S, Irino T, Fukuda K, Nakamura R, Takeuchi H, Kitagawa Y. Clinical Significance of Endoscopic Response Evaluation to Predict the Distribution of Residual Tumor after Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 34812985 DOI: 10.1245/s10434-021-11009-7] [Reference Citation Analysis]
116 Ohkura Y, Ueno M, Iizuka T, Udagawa H. Effectiveness of lymphadenectomy along the thoracic duct for radical esophagectomy. Esophagus 2021. [PMID: 34333712 DOI: 10.1007/s10388-021-00868-4] [Reference Citation Analysis]
117 Koyanagi K, Kato F, Kanamori J, Daiko H, Ozawa S, Tachimori Y. Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma: A retrospective single-institution study. Ann Gastroenterol Surg 2018;2:187-96. [PMID: 29863189 DOI: 10.1002/ags3.12069] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
118 Yoshii T, Hara H, Asayama M, Kumekawa Y, Miyazawa S, Takahashi N, Matsushima T, Shimizu S, Saito Y. Chemoradiotherapy with FOLFOX for esophageal squamous cell cancer with synchronous rectal cancer: Four case reports and a literature review. Mol Clin Oncol 2020;12:23-30. [PMID: 31814973 DOI: 10.3892/mco.2019.1945] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
119 Hirohata R, Hamai Y, Hihara J, Emi M, Kurokawa T, Yoshikawa T, Ohsawa M, Kitasaki N, Okada M. Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma. World J Surg 2022. [PMID: 35508816 DOI: 10.1007/s00268-022-06568-z] [Reference Citation Analysis]
120 Iwakiri K, Fujiwara Y, Manabe N, Ihara E, Kuribayashi S, Akiyama J, Kondo T, Yamashita H, Ishimura N, Kitasako Y, Iijima K, Koike T, Omura N, Nomura T, Kawamura O, Ohara S, Ozawa S, Kinoshita Y, Mochida S, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021. J Gastroenterol. [DOI: 10.1007/s00535-022-01861-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Yoshida M, Takizawa K, Nonaka S, Shichijo S, Suzuki S, Sato C, Komori H, Minagawa T, Oda I, Uedo N, Hirasawa K, Matsumoto K, Sumiyoshi T, Mori K, Gotoda T, Ono H, Yoshida M, Takizawa K, Ono H, Mori K, Nonaka S, Oda I, Shichijo S, Uedo N, Suzuki S, Kusano C, Gotoda T, Sato C, Hirasawa K, Komori H, Takeda T, Matsumoto K, Minagawa T, Fujii R, Sumiyoshi T, Yamasaki Y, Minashi K, Nakajima T, Kurokawa Y. Conventional versus traction-assisted endoscopic submucosal dissection for large esophageal cancers: a multicenter, randomized controlled trial (with video). Gastrointestinal Endoscopy 2020;91:55-65.e2. [DOI: 10.1016/j.gie.2019.08.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
122 Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Terata K, Imai K, Minamiya Y. Verification of the Optimal Interval Before Esophagectomy After Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer. Ann Surg Oncol 2021;28:2101-10. [PMID: 33051740 DOI: 10.1245/s10434-020-09206-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Fujita K, Motoyama S, Sato Y, Wakita A, Nagaki Y, Minamiya Y, Miura M. Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy. Esophagus 2021. [PMID: 34347217 DOI: 10.1007/s10388-021-00865-7] [Reference Citation Analysis]
124 Yamamoto M, Yamasaki M, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. New classification for the thoracic paraaortic lymph nodes of patients with esophageal squamous cell carcinoma. Surg Today 2018;48:217-22. [PMID: 28836053 DOI: 10.1007/s00595-017-1576-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
125 Cho CJ, Kang HJ, Park SJ, Kim GH, Park SH, Eo SH, Kim MJ, Kim YH, Park SR, Kim JH, Ahn JY, Kim DH, Choi KD, Song HJ, Jung HY, Park YS, Lee GH. Novel endoscopic categorization for prediction of chemoradiotherapy response in locally advanced esophageal cancer. J Gastroenterol Hepatol 2018;33:1213-9. [PMID: 29193280 DOI: 10.1111/jgh.14055] [Reference Citation Analysis]
126 Nakauchi M, Uyama I, Suda K, Shibasaki S, Kikuchi K, Kadoya S, Ishida Y, Inaba K. Robot-assisted mediastinoscopic esophagectomy for esophageal cancer: the first clinical series. Esophagus 2019;16:85-92. [PMID: 30074105 DOI: 10.1007/s10388-018-0634-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
127 Kato K, Ura T, Koizumi W, Iwasa S, Katada C, Azuma M, Ishikura S, Nakao Y, Onuma H, Muro K. Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: A phase I study. Cancer Sci 2018;109:785-93. [PMID: 29285832 DOI: 10.1111/cas.13481] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
128 Mora A, Nakajima Y, Okada T, Tokairin Y, Kawada K, Kawano T. Comparative Study of Predictive Mortality Scores in Esophagectomy with Three-Field Lymph Node Dissection in Patients with Esophageal Cancer. Dig Surg 2019;36:67-75. [PMID: 29393197 DOI: 10.1159/000486551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Okamura A, Matsuda S, Mayanagi S, Kanamori J, Imamura Y, Irino T, Kawakubo H, Mine S, Takeuchi H, Kitagawa Y, Watanabe M. Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021;28:1209-16. [PMID: 32524457 DOI: 10.1245/s10434-020-08716-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
130 Endo H, Koike T, Hatta W, Asanuma K, Uno K, Asano N, Imatani A, Watanabe M, Kato K, Masamune A. Endoscopic Findings of Esophageal Adenosquamous Carcinoma Diagnosed by Endoscopic Mucosal Resection. Case Rep Gastroenterol. 2019;13:144-152. [PMID: 31097930 DOI: 10.1159/000499182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Sato Y, Motoyama S, Wada Y, Wakita A, Kawakita Y, Nagaki Y, Terata K, Imai K, Anbai A, Hashimoto M, Minamiya Y. Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis. Cancers (Basel) 2021;13:983. [PMID: 33652817 DOI: 10.3390/cancers13050983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
132 Kubo K, Kanematsu K, Kurita D, Ishiyama K, Oguma J, Itami J, Daiko H. Feasibility of conversion thoracoscopic esophagectomy after induction therapy for locally advanced unresectable esophageal squamous cell carcinoma. Jpn J Clin Oncol 2021;51:1225-31. [PMID: 34109411 DOI: 10.1093/jjco/hyab085] [Reference Citation Analysis]
133 Chen X, He F, Chen M, Zhao F. Incidence of lymph node metastasis at each station in Siewert types Ⅱ/Ⅲ adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis. Surgical Oncology 2020;35:62-70. [DOI: 10.1016/j.suronc.2020.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
134 Matsuda S, Takeuchi H, Kawakubo H, Fukuda K, Nakamura R, Suda K, Wada N, Kitagawa Y. Prognostic Impact of Change in the Fibrinogen and Albumin Score During Preoperative Treatment in Esophageal Cancer Patients. World J Surg 2017;41:2788-95. [PMID: 28608015 DOI: 10.1007/s00268-017-4074-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
135 Ninomiya Y, Ozawa S, Oguma J, Kazuno A, Nitta M, Kajiwara H, Sato Y. Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus. Oncol Lett 2018;16:5265-74. [PMID: 30250596 DOI: 10.3892/ol.2018.9249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
136 Udagawa H, Ueno M. Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging. Ann Transl Med 2018;6:76. [PMID: 29666799 DOI: 10.21037/atm.2018.01.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
137 Wen J, Chen D, Zhao T, Chen J, Zhao Y, Liu D, Wang W, Xu X, Fan M, Chen C, Chen Y. Should the clinical significance of supraclavicular and celiac lymph node metastasis in thoracic esophageal cancer be reevaluated? Thorac Cancer 2019;10:1725-35. [PMID: 31293066 DOI: 10.1111/1759-7714.13144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
138 Onishi S, Tajika M, Tanaka T, Yamada K, Kamiya T, Abe T, Higaki E, Fujieda H, Nagao T, Inaba Y, Muro K, Shimizu M, Niwa Y. Effect of Body Composition Change during Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. J Clin Med 2022;11:508. [PMID: 35159960 DOI: 10.3390/jcm11030508] [Reference Citation Analysis]
139 Takashima S, Tanaka F, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Yamagami H, Tanigawa T, Fukumoto S, Watanabe T, Fujiwara Y. Barrett’s esophagus is negatively associated with eosinophilic esophagitis in Japanese subjects. Esophagus 2019;16:168-73. [DOI: 10.1007/s10388-018-0648-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
140 Toh Y, Yamamoto H, Miyata H, Gotoh M, Watanabe M, Matsubara H, Kakeji Y, Seto Y. Significance of the board-certified surgeon systems and clinical practice guideline adherence to surgical treatment of esophageal cancer in Japan: a questionnaire survey of departments registered in the National Clinical Database. Esophagus 2019;16:362-70. [PMID: 30980202 DOI: 10.1007/s10388-019-00672-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
141 Xu X, Xu Y, Wang J, Zhao C, Liu C, Wu B, Gao L, Dai G, Dai D. The controversy of esophageal carcinosarcoma: A case report and brief review of literature. Medicine (Baltimore) 2019;98:e14787. [PMID: 30855491 DOI: 10.1097/MD.0000000000014787] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
142 Tokairin Y, Nakajima Y, Kawada K, Hoshino A, Okada T, Ryotokuji T, Ogo T, Okuda M, Kume Y, Kawamura Y, Yamaguchi K, Nagai K, Kawano T, Kinugasa Y. A feasibility study of mediastinoscopic radical esophagectomy for thoracic esophageal cancer from the viewpoint of the dissected mediastinal lymph nodes validated with thoracoscopic procedure: a prospective clinical trial. Esophagus 2019;16:214-9. [DOI: 10.1007/s10388-018-00656-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Shiraishi O, Yasuda T, Kato H, Momose K, Hiraki Y, Yasuda A, Shinkai M, Kimura Y, Imano M. Comparison of Aggressive Planned Salvage Surgery Versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 33768398 DOI: 10.1245/s10434-021-09875-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Akaishi R, Fujishima F, Ishida H, Tsunokake J, Yamauchi T, Gokon Y, Ueki S, Fukutomi T, Okamoto H, Takaya K, Sato C, Taniyama Y, Nakamura T, Nakaya N, Kamei T, Sasano H. HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy. Cancer Rep (Hoboken) 2021;:e1477. [PMID: 34264023 DOI: 10.1002/cnr2.1477] [Reference Citation Analysis]
145 Wang Y, Ye D, Kang M, Zhu L, Yang M, Jiang J, Xia W, Kang N, Chen X, Wang J, Wang F. Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:663679. [PMID: 33981612 DOI: 10.3389/fonc.2021.663679] [Reference Citation Analysis]
146 Tokairin Y, Nakajima Y, Kawada K, Hoshino A, Okada T, Ryotokuji T, Okuda M, Kume Y, Kawamura Y, Yamaguchi K, Nagai K, Akita K, Kinugasa Y. Histological study of the thin membranous structure made of dense connective tissue around the esophagus in the upper mediastinum. Esophagus 2018;15:272-80. [DOI: 10.1007/s10388-018-0625-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
147 Kuan J, Ratcliffe E, Hayes S, McGrath S, Ang Y. Accuracy of the revised Vienna Classification for predicting postendoscopic resection outcomes for gastric and oesophageal neoplasms: a retrospective cohort study of patients from a UK tertiary referral centre. J Clin Pathol 2020;73:493-501. [PMID: 31959615 DOI: 10.1136/jclinpath-2019-206285] [Reference Citation Analysis]
148 Azuma Y, Dohi O, Naito Y, Yasuda T, Yoshida T, Ishida T, Kitae H, Matsumura S, Doi T, Hirose R, Inoue K, Yoshida N, Kamada K, Uchiyama K, Takagi T, Ishikawa T, Konishi H, Nishimura A, Kishimoto M, Itoh Y. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma. Esophagus 2021. [PMID: 34773554 DOI: 10.1007/s10388-021-00894-2] [Reference Citation Analysis]
149 Zhao B, Liang R, Li G. Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors". Ann Surg 2021;274:e681-2. [PMID: 32282378 DOI: 10.1097/SLA.0000000000003815] [Reference Citation Analysis]
150 Zhang X, Gari A, Li M, Chen J, Qu C, Zhang L, Chen J. Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03252-7] [Reference Citation Analysis]
151 Hirata A, Hayano K, Ohira G, Imanishi S, Hanaoka T, Murakami K, Aoyagi T, Shuto K, Matsubara H. Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy. Am J Surg 2020;219:1024-9. [PMID: 31387687 DOI: 10.1016/j.amjsurg.2019.07.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Zhao B, Zhang Z, Mo D, Lu Y, Hu Y, Yu J, Liu H, Li G. Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China. Front Oncol 2018;8:639. [PMID: 30719422 DOI: 10.3389/fonc.2018.00639] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Li H, Fang W, Yu Z, Mao Y, Chen L, He J, Rong T, Chen C, Chen H, Chen K, Du M, Han Y, Hu J, Fu J, Hou X, Gong T, Li Y, Liu J, Liu S, Tan L, Tian H, Wang Q, Xiang J, Xu M, Ye X, You B, Zhang R, Zhao Y; Society of Esophageal Tumor, Chinese Anti-Cancer Association. Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition). J Thorac Dis 2018;10:2481-9. [PMID: 29850156 DOI: 10.21037/jtd.2018.03.175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
154 Takeuchi M, Kawakubo H, Matsuda S, Mayanagi S, Irino T, Okui J, Fukuda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y. Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancer. World J Gastrointest Surg 2022; 14(1): 46-55 [DOI: 10.4240/wjgs.v14.i1.46] [Reference Citation Analysis]
155 Kawashima K, Abe S, Koga M, Nonaka S, Suzuki H, Yoshinaga S, Oda I, Hikichi T, Ohira H, Saito Y. Optimal selection of endoscopic resection in patients with esophageal squamous cell carcinoma: endoscopic mucosal resection versus endoscopic submucosal dissection according to lesion size. Diseases of the Esophagus 2021;34:doaa096. [DOI: 10.1093/dote/doaa096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
156 Ohkura Y, Shindoh J, Ueno M, Iizuka T, Udagawa H. Clinicopathologic Characteristics of Oligometastases from Esophageal Cancer and Long-Term Outcomes of Resection. Ann Surg Oncol 2020;27:651-9. [PMID: 31898096 DOI: 10.1245/s10434-019-08175-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
157 Chen M, Liu P, Chen Y, Chen Z, Shen M, Liu X, Li X, Li A, Lin Y, Yang R, Ni W, Zhou X, Zhang L, Tian Y, Li J, Chen J. Long Noncoding RNA FAM201A Mediates the Radiosensitivity of Esophageal Squamous Cell Cancer by Regulating ATM and mTOR Expression via miR-101. Front Genet 2018;9:611. [PMID: 30574162 DOI: 10.3389/fgene.2018.00611] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
158 Takeuchi M, Kawakubo H, Mayanagi S, Yoshida K, Fukuda K, Nakamura R, Suda K, Wada N, Takeuchi H, Kitagawa Y. Postoperative Pneumonia is Associated with Long-Term Oncologic Outcomes of Definitive Chemoradiotherapy Followed by Salvage Esophagectomy for Esophageal Cancer. J Gastrointest Surg 2018;22:1881-9. [PMID: 29980971 DOI: 10.1007/s11605-018-3857-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
159 Taniyama Y, Murakami K, Yoshida N, Takahashi K, Matsubara H, Baba H, Kamei T. Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study. BMC Cancer 2021;21:1008. [PMID: 34496769 DOI: 10.1186/s12885-021-08747-y] [Reference Citation Analysis]
160 Suetsugu T, Tanaka Y, Sato Y, Fukada M, Yasufuku I, Yoshida K. Intraperitoneal perforation through lymph node metastases in a patient with esophageal squamous cell carcinoma during intensive chemotherapy: A case report with literature review. Int J Surg Case Rep 2022;93:106944. [PMID: 35334369 DOI: 10.1016/j.ijscr.2022.106944] [Reference Citation Analysis]
161 Manabe S, Mukaisho KI, Yasuoka T, Usui F, Matsuyama T, Hirata I, Boku Y, Takahashi S. Gastric adenocarcinoma of fundic gland type spreading to heterotopic gastric glands. World J Gastroenterol 2017; 23(38): 7047-7053 [PMID: 29097877 DOI: 10.3748/wjg.v23.i38.7047] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
162 Deguchi S, Tanaka H, Suzuki S, Natsuki S, Mori T, Miki Y, Yoshii M, Tamura T, Toyokawa T, Lee S, Muguruma K, Wanibuchi H, Ohira M. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma. BMC Cancer 2022;22:699. [PMID: 35751038 DOI: 10.1186/s12885-022-09777-w] [Reference Citation Analysis]
163 Terada M, Hara H, Daiko H, Mizusawa J, Kadota T, Hori K, Ogawa H, Ogata T, Sakanaka K, Sakamoto T, Kato K, Kitagawa Y. Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE). Jpn J Clin Oncol 2019;49:1055-60. [PMID: 31411696 DOI: 10.1093/jjco/hyz112] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
164 Motoyama S, Maeda E, Yano M, Yasuda T, Ohira M, Kajiyama Y, Higashi T, Doki Y, Matsubara H. Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching. Esophagus 2020;17:141-8. [PMID: 31939000 DOI: 10.1007/s10388-019-00712-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Sakai M, Sohda M, Saito H, Kuriyama K, Yoshida T, Kumakura Y, Hara K, Yokobori T, Miyazaki T, Murata K, Noda SE, Nakano T, Kuwano H, Shirabe K. Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study. Cancer Chemother Pharmacol 2019;83:1121-6. [PMID: 30972455 DOI: 10.1007/s00280-019-03835-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
166 Izutsu M, Domoto T, Kamoshida S, Ohsaki H, Matsuoka H, Umeki Y, Shiogama K, Hirayama M, Suda K, Uyama I. Expression status of p53 and organic cation transporter 1 is correlated with poor response to preoperative chemotherapy in esophageal squamous cell carcinoma. World J Surg Oncol 2022;20:105. [PMID: 35365176 DOI: 10.1186/s12957-022-02571-9] [Reference Citation Analysis]
167 Korekawa K, Kunimitsu A, Morishima R. Microsatellite instability-high-positive cancer of unknown primary origin with a long-term survival after surgery alone: A case report. Intern Med 2022. [PMID: 35650125 DOI: 10.2169/internalmedicine.9218-21] [Reference Citation Analysis]
168 Furuhashi H, Goda K, Shimizu Y, Kato M, Takahashi M, Dobashi A, Hirata K, Oba A, Shigesawa T, Inoue M, Matsui H, Kinoshita C, Ando Y, Ikegami M, Shimoda T, Kato M. Feasibility of a simplified narrow-band imaging classification system for Barrett’s esophagus for novice endoscopists. J Gastroenterol 2019;54:587-96. [DOI: 10.1007/s00535-018-01537-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
169 Ohkura Y, Ueno M, Iizuka T, Udagawa H. Prognostic Factors and Appropriate Lymph Node Dissection in Salvage Esophagectomy for Locally Advanced T4 Esophageal Cancer. Ann Surg Oncol 2019;26:209-16. [PMID: 30465220 DOI: 10.1245/s10434-018-7074-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
170 Iwatsubo T, Ishihara R, Yamasaki Y, Tonai Y, Hamada K, Kato M, Suzuki S, Kono M, Fukuda H, Shimamoto Y, Nakagawa K, Ohmori M, Arao M, Matsuno K, Iwagami H, Inoue S, Nakahira H, Matsuura N, Shichijo S, Maekawa A, Kanesaka T, Takeuchi Y, Higashino K, Uedo N, Higuchi K. Narrow band imaging under less-air condition improves the visibility of superficial esophageal squamous cell carcinoma. BMC Gastroenterol 2020;20:389. [PMID: 33213383 DOI: 10.1186/s12876-020-01534-2] [Reference Citation Analysis]
171 Kim HE, Yang YH, Park BJ, Park SY, Min IK, Kim DJ. Skeletonizing En Bloc Esophagectomy Revisited: Oncologic Outcome in Association with the Presence of Thoracic Duct Lymph Nodes. Ann Surg Oncol 2022. [PMID: 35438467 DOI: 10.1245/s10434-022-11496-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Matsuda S, Kawakubo H, Takeuchi H, Hayashi M, Mayanagi S, Takemura R, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma. Br J Surg 2020;107:705-11. [PMID: 32077101 DOI: 10.1002/bjs.11487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
173 Hirohata R, Hamai Y, Emi M, Kurokawa T, Yoshikawa T, Ohsawa M, Tadokoro K, Okada M. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy. Surg Today 2021;51:1496-505. [PMID: 33797639 DOI: 10.1007/s00595-021-02277-7] [Reference Citation Analysis]
174 Kumagai Y, Takubo K, Sato T, Ishikawa H, Yamamoto E, Ishiguro T, Hatano S, Toyomasu Y, Kawada K, Matsuyama T, Mochiki E, Ishida H, Tada T. AI analysis and modified type classification for endocytoscopic observation of esophageal lesions. Dis Esophagus 2022:doac010. [PMID: 35292794 DOI: 10.1093/dote/doac010] [Reference Citation Analysis]
175 Motoyama S, Sato Y, Wakita A, Nagaki Y, Fujita H, Sasamori R, Kemuriyama K, Takashima S, Imai K, Minamiya Y. Lower local recurrence rate after robot-assisted thoracoscopic esophagectomy than conventional thoracoscopic surgery for esophageal cancer. Sci Rep 2021;11:6774. [PMID: 33762693 DOI: 10.1038/s41598-021-86420-x] [Reference Citation Analysis]
176 Ozawa Y, Nakano T, Taniyama Y, Sakurai T, Onodera Y, Kamiya K, Hikage M, Sato C, Takaya K, Konno T, Unno M, Kamei T. Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy. Esophagus 2019;16:345-51. [PMID: 30980203 DOI: 10.1007/s10388-019-00670-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
177 Shimada A, Tsushima T, Tsubosa Y, Booka E, Takebayashi K, Niihara M, Isaka M, Ohde Y, Machida N, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y. Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment. World J Surg 2019;43:1286-93. [PMID: 30675631 DOI: 10.1007/s00268-018-04904-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
178 Parente P, Mastracci L, Vanoli A, Businello G, Paudice M, Angerilli V, Castelvetere M, Graziano P, Fassan M, Grillo F. Colorectal Adenosquamous Carcinoma: peculiar morphologic features and distinct immunoprofiles in squamous and glandular components. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153967] [Reference Citation Analysis]
179 Okamoto H, Kikuchi H, Naganuma H, Kamei T. Multiple carcinosarcomas of the esophagus with adeno-carcinomatous components: A case report. World J Gastroenterol 2020; 26(17): 2111-2118 [PMID: 32536778 DOI: 10.3748/wjg.v26.i17.2111] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
180 Fujiwara Y, Lee S, Kishida S, Hashiba R, Gyobu K, Naka R, Nishiyama M, Ihara T, Takemura M, Osugi H. Influence of incomplete neoadjuvant chemotherapy on esophageal carcinoma. Int J Clin Oncol 2018;23:877-85. [DOI: 10.1007/s10147-018-1291-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
181 Fujishima F, Taniyama Y, Nakamura Y, Okamoto H, Ozawa Y, Ito K, Ishida H, Konno-kumagai T, Kasajima A, Taniuchi S, Watanabe M, Kamei T, Sasano H. Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy. Diseases of the Esophagus 2018;31. [DOI: 10.1093/dote/dox141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
182 Ohkura Y, Ueno M, Udagawa H. Advantageous factors of R0 curative conversion esophagectomy and the optimal extent of lymphadenectomy after induction therapy for cT4b thoracic esophageal cancer. Ann Gastroenterol Surg 2021;5:204-14. [PMID: 33860140 DOI: 10.1002/ags3.12416] [Reference Citation Analysis]
183 Chen H, Zhou X, Tang X, Li S, Zhang G. Prediction of Lymph Node Metastasis in Superficial Esophageal Cancer Using a Pattern Recognition Neural Network. Cancer Manag Res 2020;12:12249-58. [PMID: 33273861 DOI: 10.2147/CMAR.S270316] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Leng XF, Daiko H, Han YT, Mao YS. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma. Ann N Y Acad Sci 2020;1482:213-24. [PMID: 33067818 DOI: 10.1111/nyas.14508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]